PharmaShots | Incisive News in 3 Shots

Subscribe Now

All Posts by Date

Abbott's Amplatzer Piccolo Occluder Receives FDA Approval- a Medical Device for Premature and Newborns with Patent Ductus Arteriosus (PDA)

Abbott's Amplatzer Piccolo Occluder Receives FDA Approval- a Medical Device for Premature and Newborns with Patent Ductus Arterios...

January 15, 2019

Cipla Signs an Exclusive License Agreement with Bio-Thera for its BAT1706 (bevacizumab- biosimilar)

Cipla Signs an Exclusive License Agreement with Bio-Thera for its BAT1706 (bevacizumab- biosimilar)

January 15, 2019

Array Biopharma Reports Results of Triplet Combination Therapy in P-III BEACON CRC Trial for BRAF-Mutant Metastatic Colorectal Cancer (mCRC)

Array Biopharma Reports Results of Triplet Combination Therapy in P-III BEACON CRC Trial for BRAF-Mutant Metastatic Colorectal Can...

January 15, 2019

Exelixis' Cabometyx (cabozantinib) Receives FDA Approval for Previously Treated Hepatocellular Carcinoma (HCC)

Exelixis' Cabometyx (cabozantinib) Receives FDA Approval for Previously Treated Hepatocellular Carcinoma (HCC)

January 15, 2019

Bristol-Myers Squibb's (BMS) Opdivo (nivolumab) + Low-Dose Yervoy (ipilimumab) Receives EU Approval for 1L Intermediate- and Poor-Risk Advanced RCC

Bristol-Myers Squibb's (BMS) Opdivo (nivolumab) + Low-Dose Yervoy (ipilimumab) Receives EU Approval for 1L Intermediate- and Poor-...

January 15, 2019

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us